The parent company of Boots is reportedly looking into putting the UK’s high street chain of chemists on the market next year for an estimated £5bn.
Walgreen Boots Alliance (WBA), the US health group which has owned a stake in Boots since 2012, is lining up advisers from Goldman Sachs to consider a potential sale next year, according to Sky News.
A potential stock market listing for the Nottingham-based retailer and pharmacist, which has more than 2,000 outlets and employs about 55,000 people, could be considered, as well as a private sale.
WBA said it would not comment on “market speculation” and that Boots was “an important part of the group”.
However, the company said in a statement: “It is accurate that WBA announced a renewed set of
Read more on theguardian.com